{
  "overview": {
    "name": "Topic Overview",
    "children": [
      {
        "name": "Pharmacology",
        "children": [
          {
            "name": "Pharmacodynamics",
            "children": [
              {
                "name": "Mechanism of action"
              },
              {
                "name": "Animal Models of Disorders"
              },
              {
                "name": "Other"
              }
            ]
          },
          {
            "name": "Pharmacokinetics"
          },
          {
            "name": "Pharmacogenetics"
          },
          {
            "name": "Analytical Methods"
          },
          {
            "name": "Other Pharmacology"
          }
        ]
      },
      {
        "name": "Indications",
        "children": [
          {
            "name": "Depressive Disorders"
          },
          {
            "name": "Anxiety"
          },
          {
            "name": "OCD"
          },
          {
            "name": "Weight and Eating Disorders"
          },
          {
            "name": "Substance Abuse/Addictions"
          },
          {
            "name": "Other"
          }
        ]
      },
      {
        "name": "Safety",
        "children": [
          {
            "name": "Special Populations",
            "children": [
              {
                "name": "Pediatrics"
              },
              {
                "name": "Geriatrics"
              },
              {
                "name": "Other"
              }
            ]
          },
          {
            "name": "Perinatal Exposure"
          },
          {
            "name": "Other"
          }
        ]
      },
      {
        "name": "Other",
        "children": [
          {
            "name": "Ecotoxicology"
          },
          {
            "name": "Other"
          }
        ]
      }
    ]
  },
  "pharmacology": {
    "name": "Pharmacology",
    "children": [
      {
        "name": "Pharmacodynamics",
        "children": [
          {
            "name": "Mechanism of action",
            "children": [
              {
                "name": "Serotonin Receptor Modulation in SSRI Treatment"
              },
              {
                "name": "Impact of SSRIs on Neurogenesis"
              },
              {
                "name": "SSRIs Effect on Neural Processing of Emotional Cues"
              },
              {
                "name": "Neuroimaging of Serotonin Transporters"
              },
              {
                "name": "SSRIs Effects on Ion Channels"
              },
              {
                "name": "Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity"
              },
              {
                "name": "SSRIs Effect on Pulmonary Hypertension"
              },
              {
                "name": "Non-SERT Transporters in Antidepressant Action"
              },
              {
                "name": "SERT Binding Mechanisms"
              },
              {
                "name": "Astrocyte Receptors as a Target for SSRIs"
              },
              {
                "name": "SSRIs Effect on Dopamine Receptors"
              },
              {
                "name": "SSRIs Effects on Antimicrobials and Gut Microbiome"
              },
              {
                "name": "Neurometabolite Changes with Antidepressants"
              },
              {
                "name": "Galanin System in Antidepressant Action"
              },
              {
                "name": "SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients"
              }
            ]
          },
          {
            "name": "Animal Models of Disorders",
            "children": [
              {
                "name": "The Chronic Unpredictable Mild Stress Model of Depression"
              },
              {
                "name": "SSRIs in Forced Swimming Test"
              },
              {
                "name": "SSRIs Effect on Fear"
              },
              {
                "name": "Serotonergic Modulation of Cocaine Effects"
              }
            ]
          },
          {
            "name": "Other",
            "children": [
              {
                "name": "Risk of Prenatal Exposure (Rodents)"
              },
              {
                "name": "SSRIs in Model Organisms ( C. Elegans and Drosophilia)"
              }
            ]
          }
        ]
      },
      {
        "name": "Pharmacokinetics",
        "children": [
          {
            "name": "SSRIs and the Cytochrome P450 System"
          }
        ]
      },
      {
        "name": "Pharmacogenetics",
        "children": [
          {
            "name": "Serotonin Transporter Gene and Antidepressant Response"
          },
          {
            "name": "Pharmacogenetics in SSRI Treatment"
          }
        ]
      },
      {
        "name": "Analytical Methods",
        "children": [
          {
            "name": "Analytical Methods for SSRI Detection and Quantification"
          },
          {
            "name": "Paroxetine Binding to Serotonin Transporter"
          },
          {
            "name": "Synthetic Chemistry of Paroxetine"
          },
          {
            "name": "Laboratory Techniques for drug analysis"
          },
          {
            "name": "SSRI Crystal Structure and Complexation"
          }
        ]
      },
      {
        "name": "Other Pharmacology",
        "children": [
          {
            "name": "Inflammatory Biomarkers"
          },
          {
            "name": "Pharmacological Reviews"
          },
          {
            "name": "Antidepressant Drug Design"
          }
        ]
      }
    ]
  },
  "indications": {
    "name": "Indications",
    "children": [
      {
        "name": "Depressive Disorders",
        "children": [
          {
            "name": "SSRIs for Pediatric Depression"
          },
          {
            "name": "SSRIs Effect on Neural Processing of Emotional Cues"
          },
          {
            "name": "SSRIs in Forced Swimming Test"
          },
          {
            "name": "Fluvoxamine for Depression"
          },
          {
            "name": "Escitalopram for Depression"
          },
          {
            "name": "Treatment Strategies and Outcomes in Depression"
          },
          {
            "name": "SSRIs for Depression in Patients with Cardiovascular Disease"
          },
          {
            "name": "SSRIs for Bipolar Depression"
          },
          {
            "name": "Venlafaxine vs SSRIs for Depression"
          },
          {
            "name": "SSRIs for Depression in Diabetes Patients"
          },
          {
            "name": "SSRIs for Depression with Cognitive Impairment"
          },
          {
            "name": "SSRIs for Depression in Parkinsons Patients"
          },
          {
            "name": "SSRIs for Depression in in Epileptic Patients"
          },
          {
            "name": "SSRIs and Augmentation for Treatment Resistant Depression"
          },
          {
            "name": "SSRIs for Depression, Comparative Effectiveness"
          },
          {
            "name": "SSRIs for Geriatric Depression"
          },
          {
            "name": "Agomelatin for Depression"
          },
          {
            "name": "Depression Treatment Guidelines"
          },
          {
            "name": "Sertraline for Depression"
          },
          {
            "name": "SSRIs for Depression after Traumatic Brain Injury"
          },
          {
            "name": "SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients"
          },
          {
            "name": "SSRIs for Depression in Cancer Patients"
          },
          {
            "name": "SSRIs for Postpartum Depression"
          },
          {
            "name": "SSRIs Long-term Efficacy and Recurrent Depression"
          }
        ]
      },
      {
        "name": "Anxiety",
        "children": [
          {
            "name": "SSRIs Effect on Fear"
          },
          {
            "name": "SSRIs for Generalized Anxiety Disorder"
          },
          {
            "name": "SSRIs for Panic Disorder"
          },
          {
            "name": "SSRIs for Social Anxiety Disorder"
          }
        ]
      },
      {
        "name": "OCD",
        "children": [
          {
            "name": "SSRIs for OCD"
          },
          {
            "name": "SSRIs for Body Dysmorphic Disorder (BDD)"
          }
        ]
      },
      {
        "name": "Weight and Eating Disorders",
        "children": [
          {
            "name": "SSRIs for Weight Management"
          },
          {
            "name": "SSRIs for Eating Disorders"
          }
        ]
      },
      {
        "name": "Substance Abuse/Addictions",
        "children": [
          {
            "name": "SSRIs for Alcohol Dependence"
          },
          {
            "name": "Serotonergic Modulation of Cocaine Effects"
          }
        ]
      },
      {
        "name": "Other",
        "children": [
          {
            "name": "SSRIs for PTSD"
          },
          {
            "name": "SSRIs for Pain"
          },
          {
            "name": "Fluvoxamine for Covid 19"
          },
          {
            "name": "SSRIs Effect on Sleep"
          },
          {
            "name": "SSRIs for Menopausal Vasomotor Symptoms (Hot flashes)"
          },
          {
            "name": "Premature Ejaculation"
          },
          {
            "name": "SSRIs for Irritable Bowel Syndrome"
          },
          {
            "name": "SSRIs for Premenstrual Dysphoric Disorder (PMDD)"
          },
          {
            "name": "SSRIs for (Psycho)dermatological Diseases"
          },
          {
            "name": "SSRIs for Autism Spectrum Disorders"
          },
          {
            "name": "SSRIs (Fluvoxamine) for Schizophrenia"
          },
          {
            "name": "SSRIs Effect on Pulmonary Hypertension"
          },
          {
            "name": "SSRIs for Borderline Personality Disorder"
          },
          {
            "name": "Antifungal Activity of Sertraline"
          },
          {
            "name": "SSRIs for Fibromyalgia"
          }
        ]
      }
    ]
  },
  "safety": {
    "name": "Safety",
    "children": [
      {
        "name": "Special Populations",
        "children": [
          {
            "name": "Pediatrics",
            "children": [
              {
                "name": "SSRIs for Pediatric Depression"
              },
              {
                "name": "Suicice Risk"
              }
            ]
          },
          {
            "name": "Geriatrics",
            "children": [
              {
                "name": "Post-Stroke SSRI Use"
              },
              {
                "name": "SSRIs for Depression in Patients with Cardiovascular Disease"
              },
              {
                "name": "SSRIs in Dementias"
              },
              {
                "name": "SSRIs for Depression with Cognitive Impairment"
              },
              {
                "name": "SSRIs for Depression in Parkinsons Patients"
              },
              {
                "name": "SSRIs for Geriatric Depression"
              }
            ]
          },
          {
            "name": "Other",
            "children": [
              {
                "name": "SSRIs for Depression in Diabetes Patients"
              },
              {
                "name": "SSRIs for Depression in in Epileptic Patients"
              },
              {
                "name": "SSRIs for Depression after Traumatic Brain Injury"
              },
              {
                "name": "SSRIs for Depression in Cancer Patients"
              }
            ]
          }
        ]
      },
      {
        "name": "Perinatal Exposure",
        "children": [
          {
            "name": "Risk of Prenatal Exposure"
          },
          {
            "name": "Risk of Prenatal Exposure (Rodents)"
          },
          {
            "name": "SSRI Effects on Lactation"
          },
          {
            "name": "SSRIs for Postpartum Depression"
          }
        ]
      },
      {
        "name": "Other",
        "children": [
          {
            "name": "Sexual Dysfunction"
          },
          {
            "name": "Serotonin Syndrome"
          },
          {
            "name": "Bleeding Risk"
          },
          {
            "name": "Oncopreventive and Oncolytic Properties of SSRIs"
          },
          {
            "name": "Suicice Risk"
          },
          {
            "name": "Fracture Risk"
          },
          {
            "name": "Hepatotoxic Risk"
          },
          {
            "name": "Pharmacovigilance of SSRIs"
          },
          {
            "name": "QTC Prolongation"
          },
          {
            "name": "Extrapyramidal Reactions Risk"
          },
          {
            "name": "Forensic Toxicology of Fatal Overdoses"
          },
          {
            "name": "Withdrawal Symptoms"
          },
          {
            "name": "Hyponatremia Risk"
          },
          {
            "name": "SRRIs and Ocular Safety"
          }
        ]
      }
    ]
  },
  "other": {
    "name": "Other",
    "children": [
      {
        "name": "Ecotoxicology",
        "children": [
          {
            "name": "Aquatic Ecotoxicology"
          },
          {
            "name": "Environmental Degradation of Antidepressants"
          }
        ]
      },
      {
        "name": "Other",
        "children": [
          {
            "name": "SSRI Utilization Patterns"
          },
          {
            "name": "Antidepressant-like Effects of Herbal Extracts in Animal Models"
          },
          {
            "name": "Pharmacoeconomics of SSRIs for Depression"
          },
          {
            "name": "Canine Behavioral Disorders"
          }
        ]
      }
    ]
  }
}